posit
strand
rna
coronaviru
infecti
bronchiti
viru
ibv
induc
phase
arrest
reduct
phase
transit
regul
cyclin
quantit
realtim
rtpcr
western
blot
analysi
demonstr
cyclin
reduc
posttranscript
within
infect
cell
independ
cellcycl
stage
time
infect
confoc
microscopi
reveal
cyclin
decreas
ibvinfect
cell
infect
progress
inhibit
studi
indic
popul
cyclin
could
target
degrad
viru
mediat
pathway
contrast
sarscoronaviru
ibv
nucleocapsid
protein
interact
cyclin
order
growth
divis
cell
describ
cell
cycl
separ
number
distinct
phase
gap
synthesi
gap
mitosi
follow
cytokinesi
stage
cell
cycl
regul
control
posit
neg
regul
exampl
cyclin
partner
molecul
cyclin
depend
kinas
cdk
associ
inhibitor
complex
cdki
mani
virus
interact
cell
cycl
promot
favour
condit
viru
infect
disrupt
host
cell
prolifer
function
howev
alter
host
cell
cycl
rna
virus
describ
extens
compar
dna
retrovirus
coronavirus
famili
posit
strand
rna
virus
replic
cytoplasm
infect
cell
belong
order
nidoviral
infect
cell
avian
coronaviru
infecti
bronchiti
viru
ibv
caus
phase
arrest
chang
amount
protein
involv
cell
cycl
regul
reduct
cyclin
case
murin
coronaviru
mous
hepat
viru
mhv
infect
result
arrest
phase
cell
cycl
result
decreas
dtype
cyclin
overexpress
studi
indic
compon
viral
replicas
could
arrest
cell
phase
cell
cycl
hand
patient
infect
sever
acut
respiratori
syndrom
sar
coronaviru
hepatocyt
report
accumul
mitosi
contrast
number
sarscoronaviru
protein
express
lead
accumul
cell
phase
cell
cycl
exampl
sarscoronaviru
nucleocapsid
n
protein
report
block
phase
progress
prolong
phase
shorten
phase
likewis
express
ibv
n
protein
delay
cell
growth
result
aberr
cytokinesi
also
observ
infect
cell
cyclin
complex
either
cdk
posit
regul
progress
cell
phase
cell
cycl
like
cyclin
level
cyclin
fluctuat
depend
particular
stage
cell
cycl
level
cyclin
accumul
phase
cyclin
rapidli
degrad
via
cellular
proteosom
phase
allow
dna
synthesi
occur
level
begin
rise
phase
cell
cycl
regul
cyclin
express
control
abund
cyclin
mrna
sublocalis
degrad
studi
reduct
cyclin
investig
ibv
infect
cell
growth
titrat
ibv
beaudetteu
embryoadapt
ibv
strain
growth
vero
cell
perform
describ
previous
cell
cultur
experi
perform
within
subconflu
cell
avoid
artefact
popul
due
contact
inhibit
absenc
antibiot
antifung
agent
cell
infect
ibv
pfuml
moi
confluent
incub
h
viru
replac
cell
growth
media
uv
inactiv
ibv
perform
describ
previous
vero
cell
cellcycl
enrich
describ
previous
serum
depriv
doubl
thymidin
treatment
nocodazol
treatment
effici
cell
cycl
synchronis
determin
flow
cytometr
analysi
vero
cell
seed
grown
confluenc
mock
ibv
infect
pfuml
h
post
infect
cell
treat
lm
mm
licl
combin
detail
h
post
infect
cell
lyse
total
cellular
protein
quantifi
bca
assay
western
blot
analysi
perform
use
antibodi
cyclin
gapdh
ibv
protein
altern
cell
fix
made
permeabl
subsequ
immunofluores
analysi
mock
ibvinfect
vero
cell
treat
ngml
lmb
h
post
infect
h
post
infect
cell
process
appropri
either
western
blot
immunofluores
analysi
lmb
activ
shown
use
previous
describ
luciferas
assay
carri
triplic
vero
cell
cultur
six
well
plate
confluent
transfect
l
lg
plasmid
dna
use
lipofectamin
transfect
reagent
invitrogen
construct
utilis
studi
pegfpibvn
pegfpibvn
dne
use
express
either
wild
type
n
protein
n
protein
nuclear
export
signal
delet
fuse
egfp
ecfpcyclin
fusion
protein
express
plasmid
pecfpcyclin
construct
amplifi
human
cyclin
gateway
destin
vector
invitrogen
contain
cyclin
use
follow
primer
incorpor
sacii
xhoi
restrict
forward
ggaatattctcgagcgatggaacaccagctc
revers
ttattattccgcggctagatgtccacgtc
ligat
cyan
fluoresc
protein
mock
uv
inactiv
viru
treat
ibv
infect
vero
cell
harvest
h
postinfect
lyse
radioimmuoprecipit
ripa
buffer
total
protein
quantifi
bca
assay
promega
lg
total
protein
sampl
analyz
western
blot
ibv
protein
detect
chicken
antiibv
polyclon
sera
charl
river
cyclin
detect
rabbit
anticyclin
polyclon
antibodi
santa
cruz
mous
antigapdh
monoclon
antibodi
abcam
use
detect
gapdh
total
cellular
rna
extract
h
h
postinfect
rneasi
method
qiagen
cyclin
mrna
level
mock
ibv
infect
cell
treat
uvinactiv
viru
quantifi
taqman
real
time
pcr
primer
probe
cyclin
design
use
primer
express
softwar
program
appli
biosystem
cyclin
forward
primer
gtgaacaagctcaagtggaacct
revers
primer
tggcattttggaaaggaagtg
probe
tgaccccgcacgatttcatcga
forward
primer
ggcgaaagactaatcgaaccat
revers
primer
cgagagcgccagctatcct
probe
tagtagctggttccctccgaagtttccct
experi
perform
describ
previous
appropri
probe
design
across
exonexon
boundari
genom
dna
unprocess
rna
would
amplifi
ibv
genom
rna
quantifi
use
previous
describ
primerprob
set
forward
primer
cgtaccggttctgttgtgtga
revers
primer
gcccaacgctaggctcaa
probe
tcacctccccccacatacctctaaggg
quantif
base
increas
fluoresc
detect
due
exonucleas
activ
taq
dna
polymeras
pcr
amplif
hydrolys
target
specif
probe
report
signal
normalis
refer
dye
actual
involv
amplif
result
express
term
c
valu
threshold
cycl
valu
cycl
chang
report
dye
pass
signific
threshold
dr
n
variat
sampl
rna
prepar
account
standardis
c
valu
genespecif
product
sampl
c
valu
rrna
product
sampl
rna
level
sampl
experi
normalis
pool
valu
sampl
experi
calcul
mean
c
valu
rrnaspecif
gene
product
variat
individu
rrna
sampl
compar
mean
calcul
differ
input
total
rna
calcul
determin
slope
rrna
log
dilut
seri
regress
line
use
slope
respect
gene
specif
rrna
log
dilut
seri
regress
line
differ
input
total
rna
repres
rrna
use
adjust
gene
specif
c
valu
done
follow
c
mean
sampl
c
n
experiment
mean
c
mean
sampl
ibv
utribv
utr
slope
slope
result
express
valu
confoc
section
captur
use
zeiss
lsm
meta
laser
scan
confoc
microscop
nativ
cyclin
label
rabbit
anti
cyclin
santa
cruz
detect
either
goat
anti
rabbit
fitc
sigma
green
chicken
anti
rabbit
texa
red
sigma
red
appropri
ibvinfect
cell
fix
postinfect
ibv
protein
label
chicken
antiibv
polyclon
sera
charl
river
detect
rabbit
anti
chicken
antibodi
conjug
molecular
probesinvitrogen
far
red
imag
scan
four
time
cross
talk
channel
determin
switch
appropri
excit
laser
imag
correspond
emiss
cell
cotransfect
pegfpibvn
pecfpcyclin
respect
fusion
protein
analyz
metaconfoc
microscopi
determin
whether
reduct
cyclin
protein
caus
replic
viru
cellular
respons
presenc
viru
particl
amount
cyclin
protein
ibv
infect
uvinactiv
viru
treat
cell
compar
mockinfect
cell
fig
densitometr
analysi
indic
approxim
reduct
level
cyclin
protein
ibvinfect
cell
compar
either
mockinfect
cell
treat
uvinactiv
viru
data
shown
data
contrast
retroviru
hiv
dna
viru
cytomegaloviru
caus
cell
cycl
perturb
absenc
replic
viru
uvinactiv
ibv
determin
western
blot
analysi
detect
viral
protein
fig
rtpcr
viral
rna
data
shown
viral
rna
product
detect
cell
treat
uvinactiv
viru
realtim
rtpcr
taqman
use
quantifi
amount
cyclin
mrna
mockinfect
uvinactiv
viru
treat
ibvinfect
cell
total
rna
prepar
three
separ
experi
cyclin
mrna
sampl
analyz
triplic
repres
data
one
experi
shown
fig
signific
differ
level
cyclin
mrna
fig
confoc
microscopi
analysi
subcellular
localis
cyclin
green
mock
ibvinfect
red
asynchron
replic
cell
time
indic
postinfect
antibodi
control
also
present
correspond
transmiss
phase
contrast
imag
popul
suggest
reduct
cyclin
ibvinfect
cell
posttranscript
confirm
realtim
rtpcr
could
distinguish
differ
level
rna
amount
viru
rna
assay
h
pi
use
primer
probe
set
detect
viral
genom
rna
result
indic
approxim
increas
viral
genom
rna
h
postinfect
valu
indic
twofold
differ
tabl
demonstr
realtim
rtpcr
distinguish
chang
rna
level
although
ibv
infect
divid
cell
one
major
target
infect
upper
epitheli
cell
layer
contain
quiescent
cell
phase
cell
cycl
order
model
vero
cell
enrich
phase
cell
cycl
serum
starvat
confirm
flow
cytometri
fig
result
averag
cell
phase
phase
phase
cell
cycl
compar
nonconflu
asynchron
grow
cell
averag
cell
phase
phase
data
shown
cell
simultan
releas
treat
either
uvinactiv
viru
infect
ibv
level
cyclin
protein
determin
western
blot
mrna
determin
taqman
per
compar
mockinfect
cell
h
postinfect
releas
data
indic
amount
cyclin
protein
reduc
ibv
infect
cell
compar
mockinfect
uvinactiv
viru
treat
cell
fig
howev
level
cyclin
mrna
significantli
differ
cell
either
treat
ibv
uvinactiv
viru
left
untreat
fig
howev
approxim
fourfold
increas
two
valu
cyclin
mrna
cell
compar
cell
h
fig
may
reflect
increas
mrna
protein
synthesi
due
entri
cell
cycl
cyclin
mainli
function
phase
phase
transit
rapidli
degrad
via
ubiquitin
pathway
phase
cyclin
level
begin
rise
phase
therefor
investig
effect
cyclin
mrna
protein
ibvinfect
cell
enrich
either
phase
border
vero
cell
enrich
phase
use
either
doubl
thymidin
block
nocodazol
treatment
treatment
cell
cycl
profil
determin
use
dual
flow
cytometri
data
indic
cell
enrich
phase
border
fig
respect
doubl
thymidin
treat
cell
averag
cell
phase
phase
phase
cell
treat
nocodazol
averag
cell
phase
phase
describ
previous
cell
simultan
releas
treat
either
uvinactiv
viru
infect
ibv
level
cyclin
protein
determin
western
blot
mrna
determin
taqman
per
compar
mockinfect
cell
h
postinfect
releas
data
indic
amount
cyclin
protein
reduc
ibvinfect
cell
compar
mockinfect
uvinactiv
viru
treat
cell
cell
cycl
condit
fig
signific
differ
level
cyclin
mrna
condit
fig
mirror
observ
cyclin
protein
mrna
asynchron
grow
enrich
vero
cell
indic
reduct
cyclin
level
ibv
depend
cell
cycl
stage
time
infect
interestingli
cell
enrich
phase
cell
cycl
whilst
amount
cyclin
protein
greater
mockinfect
cell
h
postinfect
compar
h
infect
cell
amount
cyclin
remain
unchang
compar
h
result
could
attribut
fact
uninfect
cycl
cell
cyclin
rapidli
degrad
phase
increas
phase
wherea
ibv
arrest
cell
earli
phase
cell
cycl
therefor
cyclin
level
may
start
increas
previou
western
blot
data
indic
cyclin
protein
level
significantli
reduc
infect
cell
h
postinfect
immunofluores
analysi
cyclin
infect
cell
indic
cyclin
protein
less
mockinfect
cell
h
postinfect
absent
nucleu
h
postinfect
reflect
western
blot
analysi
fig
howev
earli
time
point
insuffici
cell
infect
distinguish
cyclin
chang
western
blot
analysi
therefor
studi
degrad
cyclin
protein
western
blot
analysi
coupl
confoc
microscopi
time
point
h
infect
utilis
replic
cell
cyclin
phosphoryl
glycogen
synthas
kinas
beta
promot
nuclear
export
subsequ
degrad
cytoplasm
howev
cyclin
also
export
degrad
independ
via
unknown
mechan
distinguish
two
possibl
cell
either
mock
infect
ibv
treat
h
postinfect
vari
concentr
licl
shown
decreas
activ
western
blot
analysi
use
detect
cyclin
ibv
gapdh
protein
data
indic
amount
cyclin
protein
greater
licl
treat
mockinfect
cell
compar
ibvinfect
cell
fig
reflect
accumul
nuclear
cyclin
reveal
immunofluores
analysi
fig
increas
concentr
licl
result
dose
depend
increas
amount
cyclin
protein
mock
infect
cell
indic
popul
cyclin
whose
nuclear
export
depend
howev
ibv
infect
licl
treat
cell
amount
cyclin
less
mockinfect
cell
therefor
indic
popul
cyclin
still
target
degrad
cyclin
export
nucleu
cytoplasm
via
exportin
test
whether
case
ibvinfect
cell
mock
infect
cell
treat
inhibitor
leptomycin
b
lmb
confirm
lmb
treatment
activ
experi
rna
export
assay
use
base
export
rev
util
pathway
luciferas
gene
place
within
ineffici
splice
intron
contain
rev
respons
element
creat
plasmid
plucsalrr
premrna
normal
retain
nucleu
export
splice
mrna
lack
luciferas
gene
export
facilit
coexpress
rev
protein
control
cmv
promot
plasmid
prev
ensur
premrna
activ
export
pathway
luciferas
activ
would
therefor
detect
presenc
lmb
would
inhibit
revdepend
mrna
export
confirm
lmb
treatment
cell
effect
block
export
pathway
therefor
order
assess
activ
lmb
vero
cell
transfect
plucsalrr
without
lmb
also
absenc
presenc
prev
fig
data
indic
absenc
prev
signific
differ
luciferas
activ
lmb
treat
untreat
cell
level
taken
background
activ
contrast
prev
protein
present
level
luciferas
less
lmb
treat
cell
compar
untreat
cell
indic
lmb
reduc
export
immunofluores
analysi
indic
mockinfect
cell
presenc
absenc
lmb
cyclin
retain
nucleu
fig
wherea
presenc
lmb
infect
cell
cyclin
observ
nucleu
although
lesser
extent
fig
stabilis
affect
lmb
cyclin
infect
cell
confirm
western
blot
analysi
fig
test
whether
degrad
cyclin
viru
infect
cell
mediat
via
cellular
proteosom
pathway
cell
either
mock
infect
ibv
treat
uvinactiv
viru
treat
h
postinfect
proteosom
inhibitor
inhibitor
use
investig
ubiquitin
mediat
degrad
cyclin
coxsacki
viru
infect
cell
western
blot
analysi
use
detect
cyclin
gapdh
ibv
protein
data
indic
cyclin
protein
treat
cell
compar
untreat
fig
confirm
immunofluores
analysi
mock
infect
cell
presenc
absenc
fig
indic
mock
ibv
infect
cell
degrad
cyclin
depend
cellular
proteosom
pathway
howev
amount
cyclin
ibv
infect
cell
less
mock
infect
cell
treat
may
popul
cyclin
degrad
via
unknown
mechan
presenc
mm
licl
lm
cyclin
level
part
stabilis
ibv
infect
cell
reveal
western
blot
immunofluores
analysi
fig
b
respect
although
variat
cell
cell
basi
indic
immunofluores
although
treatment
infect
cell
licl
lmb
result
increas
stabilis
cyclin
compar
untreat
infect
cell
still
less
cyclin
compar
mockinfect
treat
cell
indic
viral
protein
andor
signal
pathway
may
respons
export
cyclin
nucleu
cytoplasm
subsequ
degrad
one
candid
viral
protein
could
ibv
n
protein
traffic
nucleolu
cytoplasm
interact
nucleolu
protein
may
one
mechan
rna
virus
disrupt
cell
cycl
ibv
n
protein
phosphoprotein
bind
rna
high
affin
case
sever
acut
respiratori
syndrom
coronaviru
sarscov
n
protein
shown
interact
cyclin
cell
express
n
protein
investig
whether
ibv
n
protein
could
interact
cyclin
colocalis
studi
use
confoc
microscopi
pull
studi
perform
howev
colocalis
observ
cell
express
ibv
n
protein
tag
fluoresc
fusion
protein
egfp
fig
may
due
fact
ibv
n
protein
localis
princip
cytoplasm
nucleolu
rather
nucleu
contrast
cyclin
predomin
nuclear
therefor
two
molecul
could
interact
test
hypothesi
mutant
egfptag
n
protein
use
nuclear
export
signal
delet
whose
localis
nuclear
nucleolar
howev
colocalis
observ
fig
likewis
cyclin
tag
ntermin
ecfp
result
accumul
fusion
protein
predomin
cytoplasm
transfect
cell
plasmid
also
express
egfpibv
n
protein
indic
colocalis
observ
two
protein
cytoplasm
fig
interact
also
found
biochem
pull
cell
extract
use
recombin
histag
n
protein
anchor
solid
matrix
target
data
shown
wherea
control
n
protein
could
pull
tumour
suppressor
protein
fig
shown
previ
ousli
colocalis
n
protein
likewis
ibv
n
protein
colocalis
pull
nucleolin
possibl
remain
viral
protein
could
direct
traffick
cyclin
nucleu
cytoplasm
studi
demonstr
activ
replic
ibv
requir
decreas
cyclin
chang
regul
posttranscript
may
mediat
arrest
phase
cell
cycl
infect
cell
prior
stage
cyclin
level
would
usual
begin
rise
furthermor
infect
cell
cyclin
redistribut
nucleu
cytoplasm
hypothes
target
degrad
viral
protein
depend
traffick
pathway
howev
precis
mechan
pathway
remain
determin
